Barbara photo crop_edited.jpg
SCULLION STRATEGY GROUP clear - no LLC.p

BARBARA FULLER, DVM

RESEARCH SCIENTIST  

Barbara Fuller is a leading expert in discovery research, new target identification and modes of action identification.  She is experienced in the areas of dermatology, endocrinology, immunology, nephrology, cardiology, oncology and osteoarthritis in both human and veterinary medicine. She has identified and leveraged numerous human health therapeutics from a broad range of stages spanning from discovery through full product development for veterinary therapeutic application.

 

Barbara practiced veterinary clinical medicine, but determining that there were many unmet needs, returned to research to help develop needed solutions. She went on to participate in the design and execution of numerous dermatology, obesity and canine osteoarthritis studies working for multiple top tier companies including Elanco Animal Health, Novartis Animal Health and Pfizer Animal Health (now Zoetis). Prior to clinical practice, Barbara had Post-Doctoral Fellowships in Rheumatology at the University of Connecticut Health Center and in Oncology at the at the New England Deaconess Hospital where she explored AIDS lymphomas as a Harvard AIDS research Fellow. Barbara’s internships include Applied Animal Health Pharmaceutical Research at Merck Pharmaceutical Research Laboratories and co-insertion viral vector analysis at the New England Deaconess Hospital.

 

Barbara holds a DVM from Tufts University and a BS in Botany and Bacteriology from Ohio Wesleyan University.

 

 

For more information, visit

https://www.linkedin.com/in/barbara-fuller-8779ba15/